Oral Solid Dosage Contract Manufacturing Global Market Report 2024

Description

Oral solid dosage contract manufacturing involves outsourcing the production of oral solid dosage forms of pharmaceuticals to third-party manufacturers. This strategy enables pharmaceutical companies to concentrate on their core activities, such as research, development, and marketing, while utilizing the expertise and capabilities of contract manufacturing organizations (CMOs) to efficiently produce high-quality oral solid dosage pharmaceuticals.

The main product types in oral solid dosage contract manufacturing include tablets, capsules, powders, granules, and other forms. Tablets are small, solid masses of medicine containing an active drug and excipients. The services offered encompass drug product development, fill-finish product manufacturing, API manufacturing, packaging and labeling, and other applications. The therapeutic areas covered include oncology, cardiovascular diseases, metabolic disorders, neurological disorders, infectious diseases, gastrointestinal diseases, and other therapeutic areas. The end users of these services are large companies, as well as medium and small companies.

The oral solid dosage contract manufacturing market research report is one of a series of new reports from The Business Research Company that provides oral solid dosage contract manufacturing market statistics, including oral solid dosage contract manufacturing industry global market size, regional shares, competitors with a oral solid dosage contract manufacturing market share, detailed oral solid dosage contract manufacturing market segments, market trends, and opportunities, and any further data you may need to thrive in the oral solid dosage contract manufacturing industry. This oral solid dosage contract manufacturing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The oral solid dosage contract manufacturing market size has grown strongly in recent years. It will grow from $36.70 billion in 2023 to $39.39 billion in 2024 at a compound annual growth rate (CAGR) of 7.3%. The growth during the historic period can be linked to the expanding global population, the widespread occurrence of chronic diseases, and an increased emphasis on research and development.

The oral solid dosage contract manufacturing market size is expected to see strong growth in the next few years. It will grow to $52.94 billion in 2028 at a compound annual growth rate (CAGR) of 7.3%. The projected growth in the forecast period is due to more pharmaceutical companies outsourcing, progress in drug delivery technology, and heightened drug development activities. Key trends expected in this period include advancements in drug delivery technology, the integration of 3D printing, and progress in controlled-release technologies.

The surge in demand for generic drugs is anticipated to drive the growth of the oral solid dosage contract manufacturing market in the coming years. Generic drugs are medications that are bioequivalent to brand-name drugs in dosage, strength, safety, performance, quality, and intended use. The increasing demand for generic drugs is fueled by factors such as patent expirations, cost containment initiatives, regulatory incentives, and efforts to expand access to healthcare. Oral solid dosage contract manufacturing plays a pivotal role in facilitating the production and distribution of generic drugs by leveraging the capabilities of contract manufacturers to enhance operational efficiency, reduce costs, ensure high-quality production, and expedite the introduction of products to the market. For example, in 2022, the Food and Drug Administration (FDA) estimated that 91% of all prescriptions in the USA were filled with generic drugs, with over 32,000 generic drugs approved by the FDA. Consequently, the demand for generic drugs propels the growth of the oral solid dosage contract manufacturing market.

Key players in the oral solid dosage contract manufacturing market are concentrating on developing innovative solutions, such as continuous manufacturing lines, to fortify their position in the market. A continuous manufacturing line refers to a production facility or system that employs continuous manufacturing processes to produce pharmaceuticals or other products. For instance, in January 2023, WuXi STA, a pharmaceutical company based in China, inaugurated its first continuous manufacturing line for oral solid pharmaceutical products. This state-of-the-art facility represents a significant advancement in pharmaceutical production, harnessing continuous manufacturing principles to enhance efficiency, quality, and flexibility in drug manufacturing processes. This enhanced agility streamlines production timelines and minimizes downtime, ultimately expediting the delivery of essential medications to patients.

In August 2022, Catalent Inc., a US-based pharmaceutical company, completed the acquisition of Metrics Contract Services for $475 million. Through this acquisition, Catalent seeks to broaden its capabilities in the development and manufacturing of oral solid dosage forms. Metrics Contract Services is a US-based full-service contract development and manufacturing organization (CDMO) specializing in oral dosage forms.

Major companies operating in the oral solid dosage contract manufacturing market are Pfizer Inc., Takeda Pharmaceutical Company Limited, Gilead Sciences Inc., Amgen Inc., Merck KGaA, Siemens Healthineers AG, Evonik Industries AG, Teva Pharmaceutical Industries Ltd., Lonza Group AG, Catalent Inc., Patheon Pharma Services, Fareva Holding SA, Piramal Enterprises Limited, Hetero Drugs Limited, Siegfried Holding AG, Recipharm AB, Almac Group Limited, Aenova Holding GmbH, Jubilant Pharmova Limited, Cambrex Corporation, International Chemical Investors Group (ICIG) operates under the CordenPharma brand, Ajinomoto Co. Inc., Hovione Holding Ltd., Alcami Corporation

Asia Pacific was the largest region in the oral solid dosage contract manufacturing market in 2023. The regions covered in the oral solid dosage contract manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the oral solid dosage contract manufacturing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The oral solid dosage contract manufacturing market consists of revenues earned by entities by providing services such as formulation development, analytical and stability testing, and quality assurance and control. The market value includes the value of related goods sold by the service provider or included within the service offering. The oral solid dosage contract manufacturing market also consists of sales of orally disintegrating tablets (ODTS), lozenges, and chewing gums. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Oral Solid Dosage Contract Manufacturing Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on oral solid dosage contract manufacturing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for oral solid dosage contract manufacturing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The oral solid dosage contract manufacturing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Product Type: Tablets; Capsules; Powders; Granules; Other Product Types
2) By Service: Drug Product Development; Fill Finish Product Manufacturing; API Manufacturing; Packaging And Labelling; Other Applications
3) By Therapeutic Area: Oncology; Cardiovascular Diseases; Metabolic Disorders; Neurological Disorders; infectious Diseases; Gastrointestinal Diseases; Other Therapeutic Areas
4) By End User: Large Size Companies; Medium And Small Size Companies
Companies Mentioned: Pfizer Inc.; Takeda Pharmaceutical Company Limited; Gilead Sciences Inc.; Amgen Inc.; Merck KGaA
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r18688

1. Executive Summary

2. Oral Solid Dosage Contract Manufacturing Market Characteristics

3. Oral Solid Dosage Contract Manufacturing Market Trends And Strategies

4. Oral Solid Dosage Contract Manufacturing Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Oral Solid Dosage Contract Manufacturing Market Size and Growth

5.1. Global Oral Solid Dosage Contract Manufacturing Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Oral Solid Dosage Contract Manufacturing Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Oral Solid Dosage Contract Manufacturing Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Oral Solid Dosage Contract Manufacturing Market Segmentation

6.1. Global Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Tablets
Capsules
Powders
Granules
Other Product Types
6.2. Global Oral Solid Dosage Contract Manufacturing Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Drug Product Development
Fill Finish Product Manufacturing
Active Pharmaceutical Ingredient (API) Manufacturing
Packaging And Labelling
Other Applications
6.3. Global Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Oncology
Cardiovascular Diseases
Metabolic Disorders
Neurological Disorders
Infectious Diseases
Gastrointestinal Diseases
Other Therapeutic Areas
6.4. Global Oral Solid Dosage Contract Manufacturing Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Large Size Companies
Medium And Small Size Companies

7. Oral Solid Dosage Contract Manufacturing Market Regional And Country Analysis

7.1. Global Oral Solid Dosage Contract Manufacturing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Oral Solid Dosage Contract Manufacturing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Oral Solid Dosage Contract Manufacturing Market

8.1. Asia-Pacific Oral Solid Dosage Contract Manufacturing Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Oral Solid Dosage Contract Manufacturing Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Oral Solid Dosage Contract Manufacturing Market

9.1. China Oral Solid Dosage Contract Manufacturing Market Overview
9.2. China Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Oral Solid Dosage Contract Manufacturing Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Oral Solid Dosage Contract Manufacturing Market

10.1. India Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Oral Solid Dosage Contract Manufacturing Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Oral Solid Dosage Contract Manufacturing Market

11.1. Japan Oral Solid Dosage Contract Manufacturing Market Overview
11.2. Japan Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Oral Solid Dosage Contract Manufacturing Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Oral Solid Dosage Contract Manufacturing Market

12.1. Australia Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Oral Solid Dosage Contract Manufacturing Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Oral Solid Dosage Contract Manufacturing Market

13.1. Indonesia Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Oral Solid Dosage Contract Manufacturing Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Oral Solid Dosage Contract Manufacturing Market

14.1. South Korea Oral Solid Dosage Contract Manufacturing Market Overview
14.2. South Korea Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Oral Solid Dosage Contract Manufacturing Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Oral Solid Dosage Contract Manufacturing Market

15.1. Western Europe Oral Solid Dosage Contract Manufacturing Market Overview
15.2. Western Europe Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Oral Solid Dosage Contract Manufacturing Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Oral Solid Dosage Contract Manufacturing Market

16.1. UK Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Oral Solid Dosage Contract Manufacturing Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Oral Solid Dosage Contract Manufacturing Market

17.1. Germany Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Oral Solid Dosage Contract Manufacturing Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Oral Solid Dosage Contract Manufacturing Market

18.1. France Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Oral Solid Dosage Contract Manufacturing Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Oral Solid Dosage Contract Manufacturing Market

19.1. Italy Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Oral Solid Dosage Contract Manufacturing Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Oral Solid Dosage Contract Manufacturing Market

20.1. Spain Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Oral Solid Dosage Contract Manufacturing Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Oral Solid Dosage Contract Manufacturing Market

21.1. Eastern Europe Oral Solid Dosage Contract Manufacturing Market Overview
21.2. Eastern Europe Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Oral Solid Dosage Contract Manufacturing Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Oral Solid Dosage Contract Manufacturing Market

22.1. Russia Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Oral Solid Dosage Contract Manufacturing Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Oral Solid Dosage Contract Manufacturing Market

23.1. North America Oral Solid Dosage Contract Manufacturing Market Overview
23.2. North America Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Oral Solid Dosage Contract Manufacturing Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Oral Solid Dosage Contract Manufacturing Market

24.1. USA Oral Solid Dosage Contract Manufacturing Market Overview
24.2. USA Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Oral Solid Dosage Contract Manufacturing Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Oral Solid Dosage Contract Manufacturing Market

25.1. Canada Oral Solid Dosage Contract Manufacturing Market Overview
25.2. Canada Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Oral Solid Dosage Contract Manufacturing Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Oral Solid Dosage Contract Manufacturing Market

26.1. South America Oral Solid Dosage Contract Manufacturing Market Overview
26.2. South America Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Oral Solid Dosage Contract Manufacturing Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Oral Solid Dosage Contract Manufacturing Market

27.1. Brazil Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Oral Solid Dosage Contract Manufacturing Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Oral Solid Dosage Contract Manufacturing Market

28.1. Middle East Oral Solid Dosage Contract Manufacturing Market Overview
28.2. Middle East Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Oral Solid Dosage Contract Manufacturing Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Oral Solid Dosage Contract Manufacturing Market

29.1. Africa Oral Solid Dosage Contract Manufacturing Market Overview
29.2. Africa Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Oral Solid Dosage Contract Manufacturing Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Oral Solid Dosage Contract Manufacturing Market Competitive Landscape And Company Profiles

30.1. Oral Solid Dosage Contract Manufacturing Market Competitive Landscape
30.2. Oral Solid Dosage Contract Manufacturing Market Company Profiles
- 30.2.1. Pfizer Inc.
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Takeda Pharmaceutical Company Limited
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Gilead Sciences Inc.
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Amgen Inc.
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Merck KGaA
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Oral Solid Dosage Contract Manufacturing Market Other Major And Innovative Companies

31.1. Siemens Healthineers AG
31.2. Evonik Industries AG
31.3. Teva Pharmaceutical Industries Ltd.
31.4. Lonza Group AG
31.5. Catalent Inc.
31.6. Patheon Pharma Services
31.7. Fareva Holding SA
31.8. Piramal Enterprises Limited
31.9. Hetero Drugs Limited
31.10. Siegfried Holding AG
31.11. Recipharm AB
31.12. Almac Group Limited
31.13. Aenova Holding GmbH
31.14. Jubilant Pharmova Limited
31.15. Cambrex Corporation

32. Global Oral Solid Dosage Contract Manufacturing Market Competitive Benchmarking

33. Global Oral Solid Dosage Contract Manufacturing Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Oral Solid Dosage Contract Manufacturing Market

35. Oral Solid Dosage Contract Manufacturing Market Future Outlook and Potential Analysis

35.1 Oral Solid Dosage Contract Manufacturing Market In 2028 - Countries Offering Most New Opportunities
35.2 Oral Solid Dosage Contract Manufacturing Market In 2028 - Segments Offering Most New Opportunities
35.3 Oral Solid Dosage Contract Manufacturing Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer